Acculi Labs partners with vivo India to develop application for early detection of COVID-19

Faster detection of COVID-19 symptoms and rapid isolation of infected people can potentially play a decisive role in containing the disease outbreak. To capture an individual’s vital health statistics through mobile phone, Bengaluru-based IT start-up, Acculi labs has developed an application; Lyfas using vivo smartphones. By using vivo’s camera prowess, Acculi Labs has effectively managed to create an application that can help in risk assessment of an asymptomatic individual.

In its commitment to provide innovative technological solutions, vivo supported Acculi Labs in successfully testing the newly developed application by using vivo Y-series smartphones. The technology uses the power of vivo smartphone processors and sensors to capture a bunch of body signals which are then analyzed to detect the intensity of Covid-19.

Rupam Das, Founder, CEO of Acculi Labs, said, “At a time when the entire world is struggling to combat this pandemic, our endeavor was to come up with an app that helps detect asymptomatic COVID positive individual as well as assess the possibilities of these individuals becoming symptomatic in future. We are thankful to vivo India for providing us with their smartphones – vivo Y11 and Y91, during our pilot phase, which helped us develop this app. We got the best test results with vivo Y-series phones, particularly because of superior camera quality and camera position.”

Nipun Marya, Director-Brand Strategy, vivo India, said, “COVID-19 has pushed the boundaries of technological innovation across the globe. As a part of our Heroes Who Care initiative, we have continuously supported healthcare professionals working to fight the pandemic. Extending the same program, we are proud to have partnered with Acculi labs who have made this significant breakthrough. We look forward to the effective deployment of this solution in the upcoming times and hope that this will contribute significantly to contain potential Covid-19 cases in the future.”